The Genetic Research in Alzheimer Disease (GERALD) Initiative Finds rs9320913 as a Neural eQTL of lincRNA AL589740.1

Figure 1

Diagram showing GERALD project pipeline. De novo diagnoses undergo a full neuropsychological evaluation together with CNS magnetic resonance imaging (MRI). Peripheral blood extraction is used for both biochemical (BQ) analysis and DNA extraction for ApoE genotyping. Relevant data from the medical records, together with the different tests results, are integrated in a database. Subsequent follow-up results are also digitalized. Previously diagnosed patients undergo the neuropsychological evaluation which is longitudinally revised.